High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in Germany and Western Europe an inpatient setting is the current stand...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 February 2017
|
| In: |
BMC cancer
Year: 2017, Jahrgang: 17 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-017-3137-4 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-017-3137-4 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-017-3137-4 
|
| Verfasserangaben: | Katharina Lisenko, Sandra Sauer, Thomas Bruckner, Gerlinde Egerer, Hartmut Goldschmidt, Jens Hillengass, Johann W. Schmier, Sofia Shah, Mathias Witzens-Harig, Anthony D. Ho, Patrick Wuchter |
Search Result 1
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
BioMed Central; Springer 2017
Article (Journal)
Buch/Monographie
Online Resource